Canadian Sec - Delayed Quote CAD

Imagin Medical Inc. (IME.CN)

0.0150 0.0000 (0.00%)
At close: February 2 at 2:29 PM EST
Loading Chart for IME.CN
DELL
  • Previous Close 0.0150
  • Open 0.0000
  • Bid --
  • Ask 0.0250 x --
  • Day's Range 0.0150 - 0.0150
  • 52 Week Range 0.0100 - 0.2000
  • Volume 0
  • Avg. Volume 4,919
  • Market Cap (intraday) 162,451
  • Beta (5Y Monthly) 1.14
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0800
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Imagin Medical Inc., a urologic oncology company, focuses on the research, development, and commercialization of medical devices in the bio-chemistry industry. It offers the i/Blue Imaging System, which detects bladder cancer with advanced proprietary optics and light sensors; and enCage Coil, a disposable and focal therapy precision ablation device for use in the treatment of prostate cancer. The company is also developing technologies to visualize and treat urologic cancers through minimally invasive surgery, including bladder and prostate cancer. It has a license agreement with Lawrence Livermore National Security, LLC to develop and commercialize the i/Blue Imaging System. The company was founded in 1986 and is headquartered in Vancouver, Canada.

imaginmedical.com

--

Full Time Employees

September 30

Fiscal Year Ends

Related News

Performance Overview: IME.CN

Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

IME.CN
70.00%
S&P/TSX Composite index
4.37%

1-Year Return

IME.CN
92.50%
S&P/TSX Composite index
5.70%

3-Year Return

IME.CN
97.00%
S&P/TSX Composite index
14.51%

5-Year Return

IME.CN
99.17%
S&P/TSX Composite index
31.22%

Compare To: IME.CN

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: IME.CN

Valuation Measures

Annual
As of 4/25/2024
  • Market Cap

    162.45k

  • Enterprise Value

    13.71M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    -18.37

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -191.49%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -3.32M

  • Diluted EPS (ttm)

    -0.0800

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    22.17k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -241.69k

Company Insights: IME.CN

People Also Watch